Related Experiment Videos

Extended hemipelvectomy in a Jehovah's Witness with erythropoietin support

M O Meyers1, S Heinrich, R Kline

  • 1Section of Surgical Oncology, Louisiana State University Medical Center, New Orleans, USA.

The American Surgeon
|November 3, 1998
PubMed

The care of patients refusing blood transfusion who require major ablative surgery for malignancy is a continuing challenge. The use of recombinant human erythropoietin is clearly efficacious in patients with renal disease and may be useful in anemic patients who refuse transfusion. Herein, we report a successful extended hemipelvectomy in a Jehovah's Witness using recombinant human erythropoietin support.

Related Concept Videos